Author

A. Keshavan

h-index 26 View on Semantic Scholar

We have 2 of 118 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Amyloid-PET pipeline choice influences classification of preclinical Alzheimer's disease

The findings highlight the importance of considering cut-point uncertainty and methodological influences when interpreting early-stage amyloidosis and highlight the importance of considering cut-point uncertainty and methodological influences when interpreting early-stage amyloidosis.

W. Coath, A. Bollack, C. Scott et al. · medRxiv · 0 citations

Open access Jul 2026

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases

This study provides Class II evidence that plasma NfL/p-tau217 discriminates patients with CJD from those with AD and Diagnosing AD with a single abnormal p-tau plasma biomarker risks misdiagnosing prion diseases as AD.

Thomas Coysh, Rhiannon Laban, Elena Veleva et al. · Neurology · 0 citations